These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis. Kurtaran A; Raderer M; Müller C; Prokesch R; Kaserer K; Eibenberger K; Koperna K; Niederle B; Virgolini I J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133 [TBL] [Abstract][Full Text] [Related]
5. [Myocardial metastasis from carcinoid tumor in absence of liver involvement]. Amrani-Raissouni T; Moya-Espinosa P; Ramos-Moreno E; Martínez Del Valle-Torres MD; Sanz-Viedma S; Ortega-Lozano SJ Rev Esp Med Nucl; 2011; 30(6):376-7. PubMed ID: 21530011 [No Abstract] [Full Text] [Related]
6. Education and Imaging. Hepatobiliary and pancreatic: Carcinoid tumor with cystic liver metastases. Wijesuriya SR; Siriwardana R; Deen K J Gastroenterol Hepatol; 2010 Mar; 25(3):647. PubMed ID: 20370737 [No Abstract] [Full Text] [Related]
7. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report. Lobrano MB; McCarthy K; Adams L; Neitzschman H Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482 [TBL] [Abstract][Full Text] [Related]
8. Primary ovarian carcinoid: value of octreotide scintigraphy for diagnosis and correlation with other cross-sectional imaging modalities and pathology. Trapanotto V; Hamper UM; Gordon A; Krasner AS; Civelek AC J Ultrasound Med; 1997 Jul; 16(7):505-8. PubMed ID: 9315203 [No Abstract] [Full Text] [Related]
15. Localization of adrenocorticotropic hormone-secreting bronchial carcinoid tumor by somatostatin-receptor scintigraphy. Weiss M; Yellin A; Husza'r M; Eisenstein Z; Bar-Ziv J; Krausz Y Ann Intern Med; 1994 Aug; 121(3):198-9. PubMed ID: 7912484 [No Abstract] [Full Text] [Related]
16. [Somatostatin receptor scintigraphy. A new imaging procedure for the specific demonstration of carcinoids of the small intestine]. Dörr U; Räth U; Schürmann G; Höring E; Bach D; Wurm K; Scholz M; Adrian HJ; Bihl H Rofo; 1993 Jan; 158(1):67-73. PubMed ID: 8425079 [TBL] [Abstract][Full Text] [Related]
17. A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions. Minutoli F; Herberg A; Sindoni A; Cardile D; Cucinotta M; Baldari S J Endocrinol Invest; 2012 Jul; 35(7):708-9. PubMed ID: 22932274 [No Abstract] [Full Text] [Related]
18. Combined Indium-111 octreotide scintigraphy and low-dose computed tomography in localization of neuroendocrine tumors. Kjaer A; Dreyer M Clin Nucl Med; 2003 Jun; 28(6):506-8. PubMed ID: 12917538 [No Abstract] [Full Text] [Related]
19. [111In-pentetreotide in the study of tumors expressing somatostatin receptors]. Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660 [TBL] [Abstract][Full Text] [Related]
20. [Primary and follow-up studies of patients with carcinoid metastases using indium 111 octreotide--rational use of Sandostatin]. Lipp RW; Hammer HF; Passath A; Dobnig H; Ramschak-Schwarzer S; Stiegler C; Leb G; Krejs GJ Acta Med Austriaca; 1993; 20(1-2):42-4. PubMed ID: 8475679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]